Clinical Trial Update: A Study in Healthy Participants Investigating the Safety, Tolerability and Plasma Pharmacokinetics (PK) of Single Oral Doses of JNJ-47910382 [Phase 1]

View source ↗

Summary

Phase 1 study in healthy participants evaluating safety, tolerability, and plasma pharmacokinetics of single oral doses of JNJ-47910382; the trial status is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• JNJ-47910382

Snippet

Sponsor: Janssen R&D Ireland | Conditions: Hepatitis C Virus Infection | Phase 1 | Status: COMPLETED